EUVIMEDEUVIMED entdecken
Crossref

Ultra-Late Osteosarcoma Recurrences: An Analysis of 17 Cooperative Osteosarcoma Study Group Patients with a First Recurrence Detected More Than 10 Years After Primary Tumor Diagnosis

Stefanie Hecker-Nolting, Leo Kager, Thomas Kühne, Daniel Baumhoer, Claudia Blattmann, Godehard Friedel, Thekla von Kalle, Mathias Kevric, Regine Mayer-Steinacker, Rudolf Schwarz, Benjamin Sorg, Thomas Wirth und 1 weitere

Journal of Adolescent and Young Adult Oncology · 01.02.2023 · 12 (1) · 76-82

DOI: 10.1089/jayao.2021.0221 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Adolescent and Young Adult Oncology, online erschienen am 14.02.2023. Verfasst von Stefanie Hecker-Nolting und 12 weiteren Autor:innen. Beteiligte Einrichtung: Cooperative Osteosarcoma Study Group, Pediatrics 5 (Oncology, Hematology, Immunology), Center for Pediatric, Adolescent and Women's Medicine, Stuttga…. Hauptthemen laut MEDLINE: Bone Neoplasms, Osteosarcoma. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Osteosarcoma is a typical malignancy of childhood and adolescence. Recurrences usually occur early, but rarely may arise after decades of remission. Little is known about these very late events and we set out to fill this knowledge gap.

Methods

The database of the Cooperative Osteosarcoma Study Group (COSS) was searched for patients with a first recurrence of a high-grade central osteosarcoma occurring >10 years after diagnosis of the primary disease. Identified patients were analyzed for demographic, tumor-, and treatment-related factors as well as outcomes.

Results

Among a total of 1,178 10-year relapse-free survivors, 17 affected patients were identified. Only five of these had a documented good response to initial chemotherapy. No presenting factor was identified to predict these very late events. Prognosis was generally very poor despite intensive multimodal therapy. Inoperability of the recurrences seems to have constituted a major limiting factor.

Conclusion

Osteosarcoma patients should be followed for potential recurrences for well >10 years from initial diagnosis. Only through such an extended truly long-term follow-up and a structured transition of young patients can these be detected while they are still operable and, hence, potentially curable.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone NeoplasmsOsteosarcomaAdolescentHumansNeoplasm Recurrence, LocalPrognosisCombined Modality Therapy

Stichwörter der Autor:innen

chemotherapymetastasesosteosarcomaradiotherapyrecurrencesurgery

Autor:innen und Institutionen

  • Cooperative Osteosarcoma Study Group, Pediatrics 5 (Oncology, Hematology, Immunology), Center for Pediatric, Adolescent and Women's Medicine, Stuttgart Cancer Center, Klinikum Stuttgart-Olgahospital, Stuttgart, Germany.
  • Department of Pediatrics, Medical University Vienna and St. Anna Children's Cancer Research Institute (CCRI), St. Anna Children's Hospital, Vienna, Austria.
  • Department of Oncology/Hematology, University Children's Hospital Basel, Basel, Switzerland.
  • Bone Tumor Reference Center, Institute of Medical Genetics and Pathology, University Hospital Basel and University of Basel, Basel, Switzerland.
  • Clinic for Thoracic, Heart and Vascular Surgery, University Hospital Tuebingen, Tuebingen, Germany.
  • Center for Pediatric, Adolescent and Women's Medicine, Stuttgart Cancer Center, Radiologic Institute, Klinikum Stuttgart-Olgahospital, Stuttgart, Germany.

ORCID-Profile: Stefan S Bielack

Zitieren

APA

Hecker-Nolting, S., Kager, L., Kühne, T., Baumhoer, D., Blattmann, C., Friedel, G., von Kalle, T., Kevric, M., Mayer-Steinacker, R., Schwarz, R., Sorg, B., Wirth, T., & Bielack, S. S. (2023). Ultra-Late Osteosarcoma Recurrences: An Analysis of 17 Cooperative Osteosarcoma Study Group Patients with a First Recurrence Detected More Than 10 Years After Primary Tumor Diagnosis. Journal of Adolescent and Young Adult Oncology, 12(1), 76-82. https://doi.org/10.1089/jayao.2021.0221

Vancouver

Hecker-Nolting S, Kager L, Kühne T, Baumhoer D, Blattmann C, Friedel G, et al. Ultra-Late Osteosarcoma Recurrences: An Analysis of 17 Cooperative Osteosarcoma Study Group Patients with a First Recurrence Detected More Than 10 Years After Primary Tumor Diagnosis. Journal of Adolescent and Young Adult Oncology. 2023;12(1):76-82. doi:10.1089/jayao.2021.0221

BibTeX
@article{HeckerNolting2023,
  author = {Hecker-Nolting, Stefanie and Kager, Leo and Kühne, Thomas and Baumhoer, Daniel and Blattmann, Claudia and Friedel, Godehard and von Kalle, Thekla and Kevric, Mathias and Mayer-Steinacker, Regine and Schwarz, Rudolf and Sorg, Benjamin and Wirth, Thomas and Bielack, Stefan S},
  title = {Ultra-Late Osteosarcoma Recurrences: An Analysis of 17 Cooperative Osteosarcoma Study Group Patients with a First Recurrence Detected More Than 10 Years After Primary Tumor Diagnosis},
  journal = {Journal of Adolescent and Young Adult Oncology},
  year = {2023},
  volume = {12},
  number = {1},
  pages = {76--82},
  doi = {10.1089/jayao.2021.0221}
}
Kostenlos starten →